期刊文献+

益元宣肺汤对25例新冠肺炎CT值的影响

Effect of Yiyuan Xuanfei Decoction on CT Value of COVID-19 for 25 Cases
在线阅读 下载PDF
导出
摘要 目的分析深圳地区2022年新型冠状病毒肺炎患者的舌象、症状及用药史,多辨为三焦壅滞、肺脾肾虚,拟益元宣肺汤,观察其对CT值恢复的临床疗效。方法选取25例符合益元宣肺汤证型者进行治疗观察,选同期对照组25例,观察益元宣肺汤对CT值的影响。结果治疗前对照组的N基因(31.99±1.16)、O基因(33.49±1.94)与治疗组的N基因(31.45±2.85)、O基因(33.40±3.96)比较,差异无统计学意义(P>0.05);对照组治疗到CT值符合出院标准所需时间为(4.28±1.88)d,治疗组为(2.80±1.26)d,差异有统计学意义(P<0.05)。结论治疗组通过服用益元宣肺汤,CT值恢复明显比对照组快,表明以调动肺脾肾之气、疏通三焦气机为主的益元宣肺汤效果明显。扶正补肺脾肾、通宣三焦的治疗方法,在促进病情好转,加快人体清除病毒的速度方面作用明显,利于新型冠状病毒肺炎患者康复。 Objective To analyze the tongue image,symptoms and medication history of patients with novel coronavirus pneumonia in Shenzhen in 2022,most of them were identified as obstruction of three jiao and deficiency of lung,spleen and kidney,and Yiyuan Xuanfei decoction was proposed to observe its clinical effect on CT value recovery.Methods Twenty-five patients with Yiyuan Xuanfei decoction syndrome type were selected for treatment observation,and a control group of 25 cases was selected at the same time.The effect of Yiyuan Xuanfei decoction on CT value was observed.Results Before treatment,there was no significant difference between N gene(31.99±1.16)and O gene(33.49±1.94)in control group and N gene(31.45±2.85)and O gene(33.40±3.96)in treatment group(P>0.05).The time from treatment to CT value meeting discharge criteria was(4.28±1.88)d in control group and(2.80±1.26)d in treatment group,and the difference was statistically significant(P<0.05).Conclusion After taking Yiyuan Xuanfei decoction,the CT value of the treatment group recovered significantly faster than that of the control group,indicating that Yiyuan Xuanfei decoction mainly mobilized the qi of the lung,spleen and kidney and dredging the three jiao qi mechanism had obvious effect.The treatment method of strengthening the lung,spleen and kidney and promoting the three jiao has an obvious effect on promoting the improvement of the condition and speeding up the speed of the body’s elimination of the virus,which is conducive to the recovery of patients with COVID-19.
作者 李松林 张晶 刘玉娟 邓欣 刘亚峰 李琳娜 莫雨平 梁雁 LI Songlin;ZHANG Jing;LIU Yujuan;DENG Xin;LIU Yafeng;LI Linna;MO Yuping;LIANG Yan(Department of Physiotherapy,The Third People’s Hospital of Shenzhen,Guangdong Province,Shenzhen 518114,China;Department of General Practice,The Third People’s Hospital of Shenzhen,Guangdong Province,Shenzhen 518114,China;Department of Obstetrics,The Third People’s Hospital of Shenzhen,Guangdong Province,Shenzhen 518114,China;Department of Hepatology,The Third People’s Hospital of Shenzhen,Guangdong Province,Shenzhen 518114,China;Department of Traditional Chinese Medicine,The Third People’s Hospital of Shenzhen,Guangdong Province,Shenzhen 518114,China;Department of Pharmacy,The Third People’s Hospital of Shenzhen,Guangdong Province,Shenzhen 518114,China)
出处 《中国中医药现代远程教育》 2024年第1期132-135,共4页 Chinese Medicine Modern Distance Education of China
关键词 疫病 新型冠状病毒肺炎 证型特征 肺脾肾虚 寒湿 epidemic disease COVID-19 syndrome type characteristics lung spleen kidney deficiency cold dampness
作者简介 通信作者:刘亚峰,lyfff12@163.com。
  • 相关文献

参考文献5

二级参考文献45

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部